You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IgM monoclonal gammopathy

Showing 1 - 25 of 4,019
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Monoclonal Gammopathy of Uncertain Significance Trial in Utrecht (Zanubrutinib Oral Product)

Not yet recruiting
  • Monoclonal Gammopathy of Uncertain Significance
  • Zanubrutinib Oral Product
  • Utrecht, Netherlands
    University Medical Center Utrecht
Jul 6, 2023

IgA Monoclonal Gammopathy, IgG Monoclonal Gammopathy, IgM Monoclonal Gammopathy Trial in Atlanta (Rifaximin)

Recruiting
  • IgA Monoclonal Gammopathy
  • +8 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Oct 18, 2021

MRD and Clonal Evolution in Waldenström's Macroglobulinemia and

Active, not recruiting
  • Waldenstrom Macroglobulinemia
  • MRD and clonal evolution
  • Milano, MI, Italy
  • +13 more
Nov 2, 2022

Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, AHL Amyloidosis Trial in Bristol

Recruiting
  • Adenine Phosphoribosyltransferase Deficiency
  • +83 more
    • Bristol, South West, United Kingdom
      Zoe Plummer
    Sep 26, 2023

    Project in First-degree Relatives of Myeloma Patient - The

    Recruiting
    • Multiple Myeloma
    • Monoclonal Gammopathy of Undetermined Significance
    • Sample of Blood
    • Shanghai, Shanghai, China
      Zhongshan Hospital，Fudan University
    Jul 31, 2023

    Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma (SMM) Trial (Linvoseltamab)

    Not yet recruiting
    • Monoclonal Gammopathy of Undetermined Significance (MGUS)
    • Smoldering Multiple Myeloma (SMM)
    • (no location specified)
    Nov 17, 2023

    Monoclonal Gammopathy Trial in New York, Philadelphia (Isatuximab)

    Recruiting
    • Monoclonal Gammopathy
    • Boston, Massachusetts
    • +1 more
    Nov 16, 2022

    Quality of Life in Asymptomatic Monoclonal Gammopathies

    Recruiting
    • Monoclonal Gammopathy of Undetermined Significance
    • Smoldering Plasma Cell Myeloma
    • Quality-of-Life Assessment
    • Questionnaire Administration
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 25, 2022

    Peripheral Neuropathy, Monoclonal Gammopathy of Undetermined Significance Trial in Washington (Daratumumab and

    Not yet recruiting
    • Peripheral Neuropathy
    • Monoclonal Gammopathy of Undetermined Significance
    • Daratumumab and hyaluronidase-fihj
    • Washington, District of Columbia
      Lombardi Comprehensive Cancer Center, Georgetown University
    Sep 14, 2023

    Multiple Myeloma, Monoclonal Gammopathy of Renal Significance Trial in United States (Cyclophosphamide, Bortezomib,

    Recruiting
    • Multiple Myeloma
    • Monoclonal Gammopathy of Renal Significance
    • Basking Ridge, New Jersey
    • +6 more
    Oct 16, 2023

    Study in Monoclonal Gammopathy of Undetermined Significance

    Not yet recruiting
    • MGUS
      • Oxford, Oxfordshire, United Kingdom
        Secure Study
      Sep 9, 2022

      Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance Trial in United States (Whole Foods Plant-based Diet, Algae

      Recruiting
      • Multiple Myeloma
      • Monoclonal Gammopathy of Undetermined Significance
      • Whole Foods Plant-based Diet
      • +2 more
      • Basking Ridge, New Jersey
      • +6 more
      Jan 3, 2023

      Prostate Cancer, Multiple Myeloma, Smoldering Multiple Myeloma (SMM) Trial in Rochester (Curcumin plus Piperine)

      Recruiting
      • Prostate Cancer
      • +3 more
      • Curcumin plus Piperine
      • Rochester, New York
        University of Rochester
      Jun 17, 2022

      Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma Trial in United States (Metformin XR, Placebo)

      Recruiting
      • Monoclonal Gammopathy of Undetermined Significance
      • Smoldering Multiple Myeloma
      • Metformin XR
      • Placebo
      • Boston, Massachusetts
      • +6 more
      Oct 3, 2022

      Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma Trial in United States (Plant based meals)

      Recruiting
      • Monoclonal Gammopathy of Undetermined Significance
      • Smoldering Multiple Myeloma
      • Plant based meals
      • Basking Ridge, New Jersey
      • +6 more
      Apr 11, 2022

      Monoclonal Gammopathy, Smoldering Myeloma, Myeloma Trial in Cleveland (DKK1)

      Not yet recruiting
      • Monoclonal Gammopathy
      • +2 more
      • DKK1
      • Cleveland, Ohio
      • +1 more
      Nov 29, 2021

      Multicenter Case Series

      Recruiting
      • Monoclonal Gammopathy of Renal Significance
        • San Fermo Della Battaglia, Como, Italy
        • +7 more
        Jan 23, 2023

        Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma Trial in Cleveland (Multiple

        Not yet recruiting
        • Multiple Myeloma
        • +2 more
        • Multiple Myeloma M-Protein Analysis
        • Multiple Myeloma Knowledge Questionnaires
        • Cleveland, Ohio
          Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
        Apr 26, 2023

        A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

        Recruiting
        • Multiple Myeloma
        • +11 more
        • No intervention
        • Beijing, China
          Peking University First Hospital
        Apr 21, 2022

        Immune System Diseases, Autoimmune Diseases, Inflammation Trial (observational cohort study)

        Not yet recruiting
        • Immune System Diseases
        • +15 more
        • observational cohort study
        • (no location specified)
        Jul 23, 2023

        Monoclonal Gammopathy of Undetermined Significance Trial in Reykjavík (Clinical follow-up 1, Mental Health and Quality of Life

        Active, not recruiting
        • Monoclonal Gammopathy of Undetermined Significance
        • Clinical follow-up 1
        • +5 more
        • Reykjavík, Iceland
          University of Iceland
        Feb 28, 2022

        Acid Sphingomyelinase Deficiency Disease and Gaucher Disease in

        Recruiting
        • Gaucher Disease
        • Acid SphingoMyelinase Deficiency
          • Ponferrada, León, Spain
          • +11 more
          Aug 8, 2023

          Progression to Myeloma in Asymptomatic Monoclonal Gammopathies

          Recruiting
          • Monoclonal Gammopathy of Undetermined Significance
          • Smoldering Plasma Cell Myeloma
          • Biospecimen Collection
          • Laboratory Biomarker Analysis
          • Houston, Texas
            M D Anderson Cancer Center
          Oct 4, 2021

          Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Cryoglobulinemic Vasculitis Trial (Isatuximab Injection)

          Not yet recruiting
          • Multiple Myeloma
          • +2 more
          • Isatuximab Injection
          • (no location specified)
          Oct 28, 2021

          Spanish Registry of Patients With IgM Monoclonal Gammopathies

          Recruiting
          • Waldenstrom Macroglobulinemia
            • Mieres, Asturias, Spain
            • +24 more
            Jul 5, 2022